29/09, European Pitch Contest, Pre-Round 2, Cluster „NextGen Impact“, Visionaries Stage
Key Facts
Company Description
MEDEA is redefining bacteria control with a new class of natural, safe, and multifunctional antibacterial solutions for prevention and treatment. By harnessing bacteriophages – natural microorganisms – we develop products and ingredients that selectively eliminate harmful bacteria in multiple applications, solving antimicrobial resistance problem.
Product/Service Description
We started R&D with (1) veterinary therapeutics (drugs/APIs) as antibiotic alternatives for animals and (2) nutraceutical ingredients as food and feed additives for gut health in animals and humans.
Website
https://medea-bio.com
Crunchbase
Country
Germany
Founding Year
2023
Employees
5-10
Company Stage
First Pilot Customers
Business Model
B2B
Focus Industries
Active Markets
(5 most relevant ones)
US, Germany
Look for at Bits & Pretzels
Funding & Investors
3 Lead Investors
Caesar Ventures, Investitions- und Strukturbank Rheinland-Pfalz
Capital Raised to Date
1 600 000 €
Last Funding Type
Pre-Seed
Last Funding Date
December 2023
Capital Need (€)
5-15M
Currently Fundraising
(at the time of Bits & Pretzels 2025)
Yes
Growth Outlook
Traction
Multiple Commercial Partners, S2 Laboratory, 8 International Awards and 5 Accelerators.
Monetization Model
Supplying B2B Customers (Vet. Pharma, CDMOs, Nutrition Companies...) with white-label solutions.